News Sentiment

207940 sentiment intelligence

Samsung Biologics Co.,Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 55 Balanced news tone 13 relevant articles
Exchange KSC South Korea
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1395000.00 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

88/100 classification confidence.

Company focus 13

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-1.8% over one week, +7.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Samsung Biologics stock trades near record levels as contract manufacturing demand supports revenue

Market Reaction

Balanced read

67/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 88/100 classification
One-week reaction -1.8% Price digesting
Trend fit Trend inactive 7.7% over four weeks
Fair value -3.7% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 10
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 13
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
ad-hoc-news.de 4
BioWorld News 4
Reuters 2
TradingView 1
Seoul Economic Daily 1
PR Newswire 1

Event Lens

What the news is about

Classified themes
Market update 10
Earnings 2
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-13 of 13